Compare CHY & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHY | BVS |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.4M | 910.2M |
| IPO Year | 2003 | 2016 |
| Metric | CHY | BVS |
|---|---|---|
| Price | $10.61 | $10.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $16.60 |
| AVG Volume (30 Days) | 201.8K | ★ 606.9K |
| Earning Date | 01-01-0001 | 11-02-2026 |
| Dividend Yield | ★ 10.11% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $4.72 |
| Revenue Next Year | N/A | $6.41 |
| P/E Ratio | ★ N/A | $18.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.41 | $6.47 |
| 52 Week High | $13.91 | $15.89 |
| Indicator | CHY | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 35.06 | 33.79 |
| Support Level | $10.41 | $8.21 |
| Resistance Level | $12.21 | $11.00 |
| Average True Range (ATR) | 0.22 | 0.66 |
| MACD | 0.01 | -0.24 |
| Stochastic Oscillator | 5.95 | 15.20 |
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.